AAC Holdings Inc

AAC — FY2015 Earnings Presentation

20 slides from AAC's earnings presentation, Jan 27, 2016

  1. Slide 1: 2015 Year in Review, 2016 Look Ahead

    Slide 1: 2015 Year in Review, 2016 Look Ahead

    Exhibit 99.2 2015 YEAR 2016 LOOK IN AHEAD REVIEW

  2. Slide 2: Important Notice: Forward-Looking Statements

    Slide 2: Important Notice: Forward-Looking Statements

    IMPORTANT Notice These Investors assurance not quali?cations Forward-Looking re?ect Statements expressions business We assumptions, other performance section Risks, continuously de?nitive pending prohibit, maintaining recent convertible in associated the Given actual of anyunsecured this Company’s i

  3. Slide 3: Presenters

    Slide 3: Presenters

    Michael PRESENTERS Chairman At Started 20+ Kirk Chief (since Founder Stephens Co-founder 323+Foundations, years R. Executive Financial 2013) 2011) Moments Manz T. and Inc. industry management Cartwright and CEO Managing Officer CEO opened Officer ofof experience Change Foundations ofexperience Membe

  4. Slide 4: 2015 Look Back

    Slide 4: 2015 Look Back

    2015 LOOK Increased Improved Diversi?ed Divested Added Acquired Completed CSRI, Recovery Oxford Sunrise Announced Townsend, Expanded Relocated 4Unless RI Outpatient otherwise Center, House, Unpro?table 8(in-network) Admissions Bed Brands, Avg. Corp. Lab lab Payor Geography LA 5outpatient 2BACK Acqui

  5. Slide 5: Historical Revenue and Adjusted EBITDA Growth

    Slide 5: Historical Revenue and Adjusted EBITDA Growth

    HISTORICAL $200MM $250MM $REVENUE $150MM CA $100MM $28 ADJUSTED $40MM $50MM -G $30MM $20MM AEBITD $10MM 2011 $0MM $2 $7 *AAC facility 5Company’s 212 R** *Represents This $133 2012 HAS $43 losses A outlook $66 $42 114% $12 $209 GR** 65% CA 2013 EXPERIENCED quarterly EBITDA* aand $21 non-GAAP $116 GRO

  6. Slide 6: Admissions and Average Daily Census Growth

    Slide 6: Admissions and Average Daily Census Growth

    2015 2,500 ADMISSIONS 2,000 24% 1,500 1,806 1,980 1,000 AVG. Post 700 Indictment 600 500 560 QOQ 0Q 100 200 300 400 494 6AAC 1 ‘15 20% 539 CA ADMISSIONS EXPERIENCED QOQ 1,515 DAILY Q22,462 ‘15 670RESIDENTIAL Q3 ‘15AND Q4 33%‘15 CENSUS ADMISSION CENSUS GROWTH GROWTH IN THE SECOND HALF OF THE YEAR

  7. Slide 7: Acquisition Updates and Bed Growth

    Slide 7: Acquisition Updates and Bed Growth

    2015: 22% Oxford 28% Beds Current Residential Organic Sober Recovery 23% AAC 7*toAssumes reduce revenue When cost ACQUISITION Living Center Beds Residential admission First Brands per completion Beds Acquired growth Beds 76 admit IninDevelopment Bed costs has in Development 56 76 UPDATES of 2015 bee

  8. Slide 8: Organic Growth: Desert Hope and Greenhouse

    Slide 8: Organic Growth: Desert Hope and Greenhouse

    2015:1,546 Desert Greenhouse’s Greenhouse 2014 2015 8Residential 1,549 2,022 1,068 ORGANIC HopeAdmissions Hope’s2014 2015 2014 2015 07,332 3,748 GROWTH bed outpatient expansion Outpatient addition and Visits 2015 facilitated outpatient 18% addition revenue facilitated growth for70% Las Vegas revenue

  9. Slide 9: River Oaks Residential Census Growth

    Slide 9: River Oaks Residential Census Growth

    RIVER 162 175 110 125 150 100 80 090 25 50 48 58 975 STRONG#RIVER#OAKS#RESIDENTIAL#CENSUS#GROWTH /30/15 staffed staffed licensed 95 OAKS 10/31/15 beds beds beds CENSUS 11/30/15GROWTH 12/31/15 1/15/16

  10. Slide 10: Ancillary Revenue

    Slide 10: Ancillary Revenue

    ANCILLARY > 66% 100% 25% 38% 50% 75% Q1 0% 22% ‘15 Ancillary *Client 10Includes We Drug Q2 ‘15 62% 34% anticipate Related Q3 testing ’15Services 74% 26% point Q4 ‘15REVENUE Revenue is78% Ancillary of anas care essential % drug ofServices* Facility testing, component Charges asdefinitive a%to of prov

  11. Slide 11: 2016 Look Ahead: Objectives

    Slide 11: 2016 Look Ahead: Objectives

    2016in-network Objective Add Townsend Expand Offer Genetics Hematology Focus Build 11 LOOK services out onservice addiction national isacquisition to AHEAD: to materially lines laboratory third sales treatment (anticipated (anticipated party ADDICTION force diversify providers providers Q2closing th

  12. Slide 12: 2016 Look Ahead: Acquisitions and In-Network Lab

    Slide 12: 2016 Look Ahead: Acquisitions and In-Network Lab

    2016 Laguna Chemical Solutions 370 100+ Townsend, 6In-network 20 174 LAGUNA 84 12in-network beds in-network CDRH BEDS, LOOK sober Treatment Recovery, Dependency BEDS BEACH, LA—Q2 laboratory living 9AHEAD: outpatient OUTPATIENT bedsbeds Center, inNV—Q2 CA ‘16 Las DE Recovery centers Vegas CA—Q2 NOVO

  13. Slide 13: 2016 Look Ahead: Bed Capacity

    Slide 13: 2016 Look Ahead: Bed Capacity

    2016 1,117 1,200 1,500 900 996 1,061 782 600 548 0Q 300 ‘15 Total 131 Q2 ‘15 897 823 638 548 LOOK Bed 1,117 Q3 ‘15 915 638 587 Capacity Q4 ‘15 1,139 AHEAD 587 Q1 ‘16E Q2 1,115 Sta?ed ‘16E Q3 BEDQ4 ‘16E Beds CAPACITY ‘ 16E (E?ective Total Bed Capacity)

  14. Slide 14: Debt and Real Estate Assets Overview

    Slide 14: Debt and Real Estate Assets Overview

    DEBT Current Real Book River Laguna, Greenhouse, Ringwood, Sunrise, Oxford, Desert Greenhouse Recovery Total DESERT 148 14 BEDS estate $88,262,274 Value Oaks, AND Hope, Hope senior MS CA NJ HOPE First, book NJ $6,400,000 Outpatient, FL $16,261,246 $6,139,675 ASSETS TX Outpatient, NV and $6,500,000 $

  15. Slide 15: Collections and DSOs

    Slide 15: Collections and DSOs

    > 1While COLLECTIONS 99% 93 100 75 83 89 69 0Q 25 50 99.3% DSOs Q1 0.0% 51.0% 102.0% ‘14 TTM Issues Q3—Acquired Q3/Q4—Conversion Q4—ICD-10 Management 15 96 80 71 Q2 ‘14 and Cash 79 impacting 100.4% Q3 ‘14 Days 80 101% Q4 Deposits ‘14 believes conversion Sales Q1 AR 100.1% ‘15 2H Q2‘15 Outstanding to

  16. Slide 16: Case Update: Motion to Dismiss

    Slide 16: Case Update: Motion to Dismiss

    CASE > client’s Repeated Repeatedly Presenting Incorrectly Failing THE 16995FULL motions UPDATE: to death violations call instruct no advising presenting 995 was evidence the were MOTION 995 coroner aonhomicide of filed the essential MOTION inadmissible the of Grand on and probable prosecutor’s CAN

  17. Slide 17: Case Update: Coroner Declaration

    Slide 17: Case Update: Coroner Declaration

    CASE > Original Currently Dr. Declaration THE 17Declaration Fajardo FULL UPDATE: coroner Chief was DECLARATION reaffirms from Medical never of CORONER Dr. thethat original Dr. called Fajardo client Examiner-Coroner Fajardo’s drugs the to case lack CAN diagnosis DECLARATION filed testify in and of th

  18. Slide 18: 2016 Key Business Objectives

    Slide 18: 2016 Key Business Objectives

    2016 > Ramp Open Close Achieve Expand Diversify Lower Continue 18KeyBUSINESS Laguna and River business customer outpatient consistent in-network lab integrate Oaks business CDRH objectives acquisition OBJECTIVES census business occupancy pending payor in Q2for diversification costs acquisitions 2016

  19. Slide 19: Appendix: Non-GAAP Financial Measures

    Slide 19: Appendix: Non-GAAP Financial Measures

    APPENDIX: defines restructuring 2014), EPS Management EBITDA, calculations Adjusted 19 areacquisition-related Adjusted considered not EBITDA EPS Adjusted measures and charges, has believes NON-GAAP should may EBITDA included and EBITDA supplemental not reorganization of these Adjusted the be expense

  20. Slide 20: Reconciliation of Non-GAAP Disclosures

    Slide 20: Reconciliation of Non-GAAP Disclosures

    RECONCILIATION AAC Reconciliation Year 2011 (Dollars Net Non-GAAP Interest Depreciation Income Stock-based Litigation Restructuring Reorganization Acquisition-related De Adjusted 20 novo Income Ended 2012 Holdings, expense tax in start-up EBITDA settlement 2013 thousands) expense December Adjustment

Source: SEC EDGAR · 8-K filed Jan 27, 2016

More decks from AAC Holdings Inc